[ It is well known that obesity typically leads to inflammation and dysfunction of fat tissue that increases the risk of developing metabolic diseases such as diabetes and cardiovascular diseases. Source link
Read More »WHO issues first guidance on using GLP-1 drugs to treat obesity
[ The World Health Organization (WHO) released its first-ever guideline on using GLP-1 medications to treat obesity. Source link
Read More »
Recent Comments